Liver-copper levels in liver disease: studies using neutron activation analysis.
D000201:Activation Analysis; D001660:Biliary Tract Diseases / Q000175:diagnosis; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis; D002779:Cholestasis / Q000175:diagnosis; D003300:Copper / Q000032:analysis* / Q000378:metabolism; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000175:diagnosis; D006506:Hepatitis A / Q000175:diagnosis; D006527:Hepatolenticular Degeneration / Q000175:diagnosis; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000175:diagnosis; D007566:Jaundice, Chronic Idiopathic / Q000175:diagnosis; D008103:Liver Cirrhosis / Q000175:diagnosis; D008105:Liver Cirrhosis, Biliary / Q000175:diagnosis; D008107:Liver Diseases / Q000175:diagnosis* / Q000378:metabolism; D010396:Penicillamine / Q000627:therapeutic use
D003300:Copper; D010396:Penicillamine